Home » Authors » Harry Ustik, CGT Manufacturing Expert, PA Consulting

Harry Ustik, CGT Manufacturing Expert, PA Consulting

Articles

ARTICLES

PHARMACEUTICALS/BIO-TECH

Five Key Manufacturing Challenges in Autologous Commercial Cell and Gene Therapies

February 5, 2024

Paolo Siciliano, Cell and Gene Expert, PA Consulting, Martin Sowden, Pharma Supply Chain Expert, PA Consulting, Shanton Wilcox, U.S. Manufacturing Lead, PA Consulting, and Harry Ustik, CGT Manufacturing Expert, PA Consulting

The personalized nature of autologous CGT results in complex manufacturing challenges, driving costs high when transitioning from clinical to commercial scale.

How China Might Get Around the U.S. Ban on Imports Made With Forced Labor
Supply Chain Visibility
Canada Moves to Force an End to Postal Strike
Last Mile Delivery
Port of Portland Finds New Operator for Terminal 6
Global Gateways
Watch: The Impact of New Tariffs on Durable Goods Sellers
Regulation & Compliance
Senate Probe Claims Amazon Ignored Warehouse Safety Warnings
Business Strategy Alignment

Digital Edition

Supply Chain Innovation 2024: A Formula for Thriving in the Age of Disruption

VIEW THE LATEST ISSUE

Case Studies

Recycled Tagging Fasteners: Small Changes Make a Big Impact
Enhancing High-Value Electronics Shipment Security with Tive's Real-Time Tracking
Moving Robots Site-to-Site
JLL Finds Perfect Warehouse Location, Leading to $15M Grant for Startup
Robots Speed Fulfillment to Help Apparel Company Scale for Growth

Visit Our Sponsors

ARTICLES

Subscribe to our Daily Newsletter!

Popular Stories

Visit Our Sponsors